Phase2 study on the validity of initiating treatment during midtrimester for GDM patients

Phase2 study on the validity of initiating treatment during midtrimester for GDM patients - GDM intervention trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030231

Enrollment

150

Registered

2017-12-05

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GDM

Interventions

Treatment timing for GDM patients

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: early onset mild GDM

Exclusion criteria

Exclusion criteria: overt DM

Design outcomes

Primary

Measure	Time frame
large for gestational age(%)	—

Secondary

Measure	Time frame
Incidence of macrosomia SGA shoulder dystocia GDM associated neonatal complications	—

Countries

Japan

Contacts

Public ContactShigeru Aoki

Yokohama City University Medical Center Perinatal Center for Maternity and Neonate

smyyaoki@yokohama-cu.ac.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026